Is a complete BCBA/VRTX research report available?

No complete published report is available for bcba/VRTX (BCBA/VRTX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/VRTX (BCBA/VRTX)

Buenos Aires Stock Exchange: BCBA/VRTX · ARS

ARS 8,495

-79.75 (-0.9%)· Recorded snapshot

Market cap	203.1T
Revenue (ttm)	18.6T
Net income (ttm)	6.5T
EPS (ttm)	ARS 262
P/E (trailing)	32.5x
P/E (forward)	28.8x
Volume	2,331

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 18.6T
Net income (ttm): 6.5T
EPS (ttm): ARS 262
P/E (trailing): 32.5x
P/E (forward): 28.8x
Market cap: 203.1T

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-11-02
Employees	6,400
Employees change	300
Employees growth	4.92%
Enterprise value	ARS 185.2T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1989
Industry	Biotechnology
Is primary listing	No
ISIN number	AR0468655268
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Market cap	ARS 203.1T
Next earnings date	2026-11-02
Price	ARS 8,495.00
Price currency	ARS
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	bcba/VRTX
Website	https://www.vrtx.com

Metric

Value

Amount currency

ARS

Country

United States

Country code

Earnings date

2026-11-02

Employees

6,400

Employees change

300

Employees growth

4.92%

Enterprise value

ARS 185.2T

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

1989

Industry

Biotechnology

Is primary listing

ISIN number

AR0468655268

Last earnings date

2026-08-03

Last refreshed

2026-10-28

Market cap

ARS 203.1T

Next earnings date

2026-11-02

Price

ARS 8,495.00

Price currency

ARS

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-27

Symbol

bcba/VRTX

Website

https://www.vrtx.com

Metric	Value
Average P/E ratio (10Y)	50.03x
Average P/E ratio (3Y)	28.04x
Average P/E ratio (5Y)	26.01x
Earnings yield	3.08%
EV/Earnings	28.38x
EV/EBIT	24.52x
EV/EBITDA	22.32x
EV/FCF	32.93x
EV/Sales	9.57x
FCF / EV yield	3.04%
FCF yield	2.77%
Forward P/E	28.82x
Graham number	2770.60763
Graham upside	-67.33%
Lynch fair value	ARS 4,687.31
Lynch upside	-44.73%
P/(FCF - SBC) ratio	44.13x
P/(OCF - SBC) ratio	38.05x
P/B ratio	6.77x
P/E ratio	32.46x
P/FCF ratio	36.12x
P/OCF ratio	31.94x
P/S ratio	10.89x
Price / tangible book value	7.31x
Price/EBITDA ratio	26.88x

Metric

Value

Average P/E ratio (10Y)

50.03x

Average P/E ratio (3Y)

28.04x

Average P/E ratio (5Y)

26.01x

Earnings yield

3.08%

EV/Earnings

28.38x

EV/EBIT

24.52x

EV/EBITDA

22.32x

EV/FCF

32.93x

EV/Sales

9.57x

FCF / EV yield

3.04%

FCF yield

2.77%

Forward P/E

28.82x

Graham number

2770.60763

Graham upside

-67.33%

Lynch fair value

ARS 4,687.31

Lynch upside

-44.73%

P/(FCF - SBC) ratio

44.13x

P/(OCF - SBC) ratio

38.05x

P/B ratio

6.77x

P/E ratio

32.46x

P/FCF ratio

36.12x

P/OCF ratio

31.94x

P/S ratio

10.89x

Price / tangible book value

7.31x

Price/EBITDA ratio

26.88x

Metric	Value
EBIT margin	39%
EBITDA margin	40.52%
Effective tax rate	16.48%
FCF margin	29.05%
Gross margin	54.96%
Operating margin	39%
Pretax margin	41.9%
Profit margin	35%
Profit per employee	ARS 1B
Profitable quarters	8
Profitable years	1
Revenue per employee	ARS 2.9B
ROA	11.93%
ROA (5Y)	14.82%
ROCE	20.9%
ROE	23.54%
ROE (5Y)	19%
ROIC	28.8%
ROIC (5Y)	37.75%
SBC / revenue	5.47%
Tax / revenue	6.91%

Metric

Value

EBIT margin

39%

EBITDA margin

40.52%

Effective tax rate

16.48%

FCF margin

29.05%

Gross margin

54.96%

Operating margin

39%

Pretax margin

41.9%

Profit margin

35%

Profit per employee

ARS 1B

Profitable quarters

Profitable years

Revenue per employee

ARS 2.9B

ROA

11.93%

ROA (5Y)

14.82%

ROCE

20.9%

ROE

23.54%

ROE (5Y)

19%

ROIC

28.8%

ROIC (5Y)

37.75%

SBC / revenue

5.47%

Tax / revenue

6.91%

Metric	Value
EPS growth	22.12%
EPS growth (Q)	8.02%
EPS growth (QoQ)	7.21%
EPS growth 3Y	9.92%
EPS growth 5Y	17.77%
EPS growth quarters	5
EPS growth years	1
FCF growth	8.47%
FCF growth (Q)	9.25%
FCF growth (QoQ)	-21.74%
FCF growth 3Y	-0.71%
FCF growth 5Y	16.39%
Gross profit growth	15.3%
Gross profit growth (Q)	17.23%
Gross profit growth 3Y	8.01%
Gross profit growth 5Y	11.52%
Net income growth	21.1%
Net income growth (Q)	6.48%
Net income growth (QoQ)	6.63%
Net income growth 3Y	9.4%
Net income growth 5Y	17.2%
Net income growth quarters	5
Net income growth years	1
OCF growth	11.61%
OCF growth (Q)	4.87%
OCF growth (QoQ)	-21.2%
OCF growth 3Y	1.81%
OCF growth 5Y	15.15%
Operating income growth	10.85%
Operating income growth (Q)	9.92%
Operating income growth 3Y	3.16%
Operating income growth 5Y	8.75%
Revenue growth	10.23%
Revenue growth (Q)	12.45%
Revenue growth (QoQ)	11.62%
Revenue growth 10Y	23.24%
Revenue growth 3Y	9.81%
Revenue growth 5Y	13.5%
Revenue growth quarters	33
Revenue growth years	11

Metric

Value

EPS growth

22.12%

EPS growth (Q)

8.02%

EPS growth (QoQ)

7.21%

EPS growth 3Y

9.92%

EPS growth 5Y

17.77%

EPS growth quarters

EPS growth years

FCF growth

8.47%

FCF growth (Q)

9.25%

FCF growth (QoQ)

-21.74%

FCF growth 3Y

-0.71%

FCF growth 5Y

16.39%

Gross profit growth

15.3%

Gross profit growth (Q)

17.23%

Gross profit growth 3Y

8.01%

Gross profit growth 5Y

11.52%

Net income growth

21.1%

Net income growth (Q)

6.48%

Net income growth (QoQ)

6.63%

Net income growth 3Y

9.4%

Net income growth 5Y

17.2%

Net income growth quarters

Net income growth years

OCF growth

11.61%

OCF growth (Q)

4.87%

OCF growth (QoQ)

-21.2%

OCF growth 3Y

1.81%

OCF growth 5Y

15.15%

Operating income growth

10.85%

Operating income growth (Q)

9.92%

Operating income growth 3Y

3.16%

Operating income growth 5Y

8.75%

Revenue growth

10.23%

Revenue growth (Q)

12.45%

Revenue growth (QoQ)

11.62%

Revenue growth 10Y

23.24%

Revenue growth 3Y

9.81%

Revenue growth 5Y

13.5%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	ARS -736B
Depreciation and amortization	ARS 293.7B
EBIT	ARS 7.3T
EBITDA	ARS 7.6T
EPS	ARS 261.69
Financing cash flow	ARS -3.3T
Free cash flow	ARS 5.6T
Free cash flow minus SBC	ARS 4.6T
Gross profit	ARS 10.2T
Income taxes	ARS 1.3T
Investing cash flow	ARS -1.3T
Net borrowing	ARS -8.3B
Net cash flow	ARS 1.7T
Net income	ARS 6.5T
Operating cash flow minus SBC	ARS 5.3T
Operating income	ARS 7.3T
Revenue	ARS 18.6T
Stock-based compensation	ARS 1T

Metric

Value

Capital expenditures

ARS -736B

Depreciation and amortization

ARS 293.7B

EBIT

ARS 7.3T

EBITDA

ARS 7.6T

EPS

ARS 261.69

Financing cash flow

ARS -3.3T

Free cash flow

ARS 5.6T

Free cash flow minus SBC

ARS 4.6T

Gross profit

ARS 10.2T

Income taxes

ARS 1.3T

Investing cash flow

ARS -1.3T

Net borrowing

ARS -8.3B

Net cash flow

ARS 1.7T

Net income

ARS 6.5T

Operating cash flow minus SBC

ARS 5.3T

Operating income

ARS 7.3T

Revenue

ARS 18.6T

Stock-based compensation

ARS 1T

Metric	Value
Altman Z-Score	11.58
Book value per share	ARS 118,403.60
Debt / EBITDA	0.37
Debt / equity	0.1
Debt / FCF	0.52
Goodwill	ARS 1.7T
Interest coverage	369.14
Long-term assets	ARS 21.3T
Long-term liabilities	ARS 4.6T
Net cash (debt)	ARS 17.3T
Net cash / market cap	8.51%
Net cash growth	11.07%
Net debt / EBITDA	-2.29
Net debt / equity	-0.58
Net debt / FCF	-3.07
Piotroski F-Score	5
Property, plant and equipment	ARS 5.1T
Shareholders' equity	ARS 30T
Tangible book value	ARS 27.8T
Tangible book value per share	ARS 109,627.38
Total assets	ARS 40.6T
Total cash	ARS 11.6T
Total debt	ARS 2.9T
Total liabilities	ARS 10.6T

Metric

Value

Altman Z-Score

11.58

Book value per share

ARS 118,403.60

Debt / EBITDA

0.37

Debt / equity

0.1

Debt / FCF

0.52

Goodwill

ARS 1.7T

Interest coverage

369.14

Long-term assets

ARS 21.3T

Long-term liabilities

ARS 4.6T

Net cash (debt)

ARS 17.3T

Net cash / market cap

8.51%

Net cash growth

11.07%

Net debt / EBITDA

-2.29

Net debt / equity

-0.58

Net debt / FCF

-3.07

Piotroski F-Score

Property, plant and equipment

ARS 5.1T

Shareholders' equity

ARS 30T

Tangible book value

ARS 27.8T

Tangible book value per share

ARS 109,627.38

Total assets

ARS 40.6T

Total cash

ARS 11.6T

Total debt

ARS 2.9T

Total liabilities

ARS 10.6T

Metric	Value
Asset turnover	0.49
Current assets	ARS 19.3T
Current liabilities	ARS 6.1T
Current ratio	3.19
Inventory turnover	3.47
Net working capital	ARS 1.1T
Quick ratio	2.54
Working capital	ARS 12.7T
Working capital turnover	2,503.87

Metric

Value

Asset turnover

0.49

Current assets

ARS 19.3T

Current liabilities

ARS 6.1T

Current ratio

3.19

Inventory turnover

3.47

Net working capital

ARS 1.1T

Quick ratio

2.54

Working capital

ARS 12.7T

Working capital turnover

2,503.87

Metric	Value
Buyback yield / dilution	0.85%
Shareholder yield	0.85%

Metric

Value

Buyback yield / dilution

0.85%

Shareholder yield

0.85%

Metric	Value
150-day SMA	ARS 7,393.80
1D price change	-0.93%
1M price change	0.71%
1M total return	0.71%
1W price change	5.73%
1W total return	5.73%
1Y price change	30.49%
1Y return CAGR	30.52%
1Y total return	30.49%
20-day SMA	ARS 8,209.25
200-day SMA	ARS 7,273.23
3M price change	12.74%
3M total return	12.74%
50-day SMA	ARS 8,320.70
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 8,825.00
52-week high date	2026-09-03
52-week low	ARS 5,545.00
52-week low date	2025-10-27
6M price change	32.42%
6M total return	32.42%
All-time high	ARS 8,825.00
All-time high date	2026-09-03
All-time low	ARS 4,815.00
All-time low date	2025-08-08
Average true range (ATR)	ARS 227.62
Average volume	2.6K
Change from 52-week high	-3.74%
Change from 52-week low	53.2%
Change from all-time high	-3.74%
Change from all-time low	76.43%
Change from open	0.3%
Day's gap	-1.22%
Dollar volume	ARS 19.8M
High price	ARS 8,555.00
Low price	ARS 8,425.00
Monthly RSI	67.91
Open price	ARS 8,470.00
Position in 52-week range	53.85%
Previous close	ARS 8,575.00
Price vs 150-day SMA	14.89%
Price vs 20-day SMA	3.48%
Price vs 200-day SMA	16.8%
Price vs 50-day SMA	2.09%
Relative volume	0.89
RSI	57.08
Sharpe ratio	1.05
Sortino ratio	1.85
Volume	2.3K
Weekly RSI	60.58
YTD price change	24.2%
YTD total return	24.2%

Metric

Value

150-day SMA

ARS 7,393.80

1D price change

-0.93%

1M price change

0.71%

1M total return

0.71%

1W price change

5.73%

1W total return

5.73%

1Y price change

30.49%

1Y return CAGR

30.52%

1Y total return

30.49%

20-day SMA

ARS 8,209.25

200-day SMA

ARS 7,273.23

3M price change

12.74%

3M total return

12.74%

50-day SMA

ARS 8,320.70

50-day SMA vs 200-day SMA

50over200

52-week high

ARS 8,825.00

52-week high date

2026-09-03

52-week low

ARS 5,545.00

52-week low date

2025-10-27

6M price change

32.42%

6M total return

32.42%

All-time high

ARS 8,825.00

All-time high date

2026-09-03

All-time low

ARS 4,815.00

All-time low date

2025-08-08

Average true range (ATR)

ARS 227.62

Average volume

2.6K

Change from 52-week high

-3.74%

Change from 52-week low

53.2%

Change from all-time high

-3.74%

Change from all-time low

76.43%

Change from open

0.3%

Day's gap

-1.22%

Dollar volume

ARS 19.8M

High price

ARS 8,555.00

Low price

ARS 8,425.00

Monthly RSI

67.91

Open price

ARS 8,470.00

Position in 52-week range

53.85%

Previous close

ARS 8,575.00

Price vs 150-day SMA

14.89%

Price vs 20-day SMA

3.48%

Price vs 200-day SMA

16.8%

Price vs 50-day SMA

2.09%

Relative volume

0.89

RSI

57.08

Sharpe ratio

1.05

Sortino ratio

1.85

Volume

2.3K

Weekly RSI

60.58

YTD price change

24.2%

YTD total return

24.2%

Metric	Value
Float	252.7M
Shares change (QoQ)	-0.43%
Shares change (YoY)	-0.85%
Shares held by insiders	0.2%
Shares held by institutions	97.11%
Short ratio	3.6 days

Metric

Value

Float

252.7M

Shares change (QoQ)

-0.43%

Shares change (YoY)

-0.85%

Shares held by insiders

0.2%

Shares held by institutions

97.11%

Short ratio

3.6 days

BCBA/VRTX (BCBA/VRTX)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/VRTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/VRTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/VRTX

Frequently asked questions